Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence
Advanced Healthcare Materials · 2024-03 · 13 (6)
DOI: 10.1002/adhm.202303031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.11.2023. Verfasst von Ye Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Interventional Radiology, Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nanoparticles. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project funded by China Postdoctoral Science Foundation, Guangzhou Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Thermal ablation is a crucial therapeutic modality for hepatocellular carcinoma (HCC), but its efficacy is often hindered by the high recurrence rate attributed to insufficient ablation. Furthermore, the residual tumors following insufficient ablation exhibit a more pronounced immunosuppressive state, which accelerates the disease progression and leads to immune checkpoint blockade (ICB) resistance. Herein, evidence is presented that heightened intratumoral lactate accumulation, stemming from the augmented glycolytic activity of postablative residual HCC cells, may serve as a crucial driving force in exacerbating the immunosuppressive state of the tumor microenvironment (TME). To address this, an injectable nanoparticles‐hydrogel composite system (LOX‐MnO 2 @Gel) is designed that gradually releases lactate oxidase (LOX)‐loaded hollow mesoporous MnO 2 nanoparticles at the tumor site to continuously deplete intratumoral lactate via a cascade catalytic reaction. Using subcutaneous and orthotopic HCC tumor‐bearing mouse models, it is confirmed that LOX‐MnO 2 @Gel‐mediated local lactate depletion can transform the immunosuppressive postablative TME into an immunocompetent one and synergizes with ICB therapy to significantly inhibit residual HCC growth and lung metastasis, thereby prolonging the survival of mice postablation. The work proposes an appealing strategy for synergistically combining antitumor metabolic therapy with immunotherapy to combat postablative HCC recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Interventional Radiology, Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province,…
- Key Laboratory of Surveillance of Adverse Reactions Related to CAR T Cell Therapy, Department of Immuno-Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, 5100…
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Pro…
- Nanomedicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, 510630, China.
- Department of Ultrasound, Institute of Ultrasound in Musculoskeletal Sports Medicine, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong Province, 510310, China.
ORCID-Profile: Ye Chen, Jiaxin Bei, Meijuan Chen, Zecong Xiao, Zhili Xu, Kangshun Zhu
Förderung
- National Natural Science Foundation of China
- Project funded by China Postdoctoral Science Foundation
- Guangzhou Basic and Applied Basic Research Foundation
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Chen, Y., Bei, J., Chen, M., Cai, W., Zhou, Z., Cai, M., Huang, W., Lin, L., Guo, Y., Liu, M., Huang, X., Xiao, Z., Xu, Z., & Zhu, K. (2024). Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Advanced Healthcare Materials, 13(6). https://doi.org/10.1002/adhm.202303031
Vancouver
Chen Y, Bei J, Chen M, Cai W, Zhou Z, Cai M, et al. Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Advanced Healthcare Materials. 2024;13(6). doi:10.1002/adhm.202303031
BibTeX
@article{Chen2024,
author = {Chen, Ye and Bei, Jiaxin and Chen, Meijuan and Cai, Weiguo and Zhou, Zhimei and Cai, Mingyue and Huang, Wensou and Lin, Liteng and Guo, Yongjian and Liu, Mingyu and Huang, Xinkun and Xiao, Zecong and Xu, Zhili and Zhu, Kangshun},
title = {Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {6},
doi = {10.1002/adhm.202303031}
}
EUVIMED